We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Top Buys

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.7M
2
IMVT icon
Immunovant
IMVT
+$15.7M
3
LL
LL Flooring Holdings, Inc.
LL
+$11.4M
4
ACET icon
Adicet Bio
ACET
+$10.9M
5
INVZ icon
Innoviz Technologies
INVZ
+$9.95M

Top Sells

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$131M
2
IMCR icon
Immunocore
IMCR
+$34.1M
3
FTAI icon
FTAI Aviation
FTAI
+$28.1M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$20.8M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGC
51
DELISTED
Northern Genesis Acquisition Corp. III
NGC
$2.52M 0.26%
+250,810
New +$2.49M
DTRT
52
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
$2.33M 0.24%
+224,845
New +$2.3M
XGN icon
53
Exagen
XGN
$161M
$2.32M 0.24%
966,022
-363,361
-27% -$932K
MBI icon
54
MBIA
MBI
$257M
$2.28M 0.24%
177,296
+67,998
+62% +$777K
TGT icon
55
PUT
Target
TGT
$69B
$2.2M 0.23%
+19,900
New +$3.12M
DRAY
56
DELISTED
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
$2.19M 0.23%
+215,000
New +$2.17M
RNW icon
57
ReNew
RNW
$2.23B
$2.1M 0.22%
381,900
+195,332
+105% +$1.14M
TARO
58
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2.05M 0.21%
+70,606
New +$2.09M
CNGL
59
DELISTED
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
$2.04M 0.21%
+200,000
New +$2.04M
MCAG
60
DELISTED
Mountain Crest Acquisition Corp. V Common Stock
MCAG
$2.01M 0.21%
+200,000
New +$2M
APGB
61
DELISTED
Apollo Strategic Growth Capital II
APGB
$1.89M 0.2%
+188,459
New +$1.88M
HHLA
62
DELISTED
HH&L Acquisition Co.
HHLA
$1.88M 0.2%
+185,523
New +$1.86M
SDST
63
Stardust Power Inc
SDST
$7.27M
$1.83M 0.19%
+18,094
New +$1.82M
POW
64
DELISTED
Powered Brands Class A Ordinary Shares
POW
$1.76M 0.18%
+174,042
New +$1.75M
BWAC
65
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
$1.68M 0.18%
160,991
– –
MUFG icon
66
Mitsubishi UFJ Financial
MUFG
$251B
$1.67M 0.17%
250,000
– –
ACI icon
67
Albertsons Companies
ACI
$5.89B
$1.65M 0.17%
+79,547
New +$1.75M
TEVA icon
68
Teva Pharmaceuticals
TEVA
$42.1B
$1.61M 0.17%
176,942
-276,858
-61% -$2.42M
ATMVU
69
DELISTED
AlphaVest Acquisition Corp Unit
ATMVU
$1.51M 0.16%
+150,000
New +$1.51M
CCV
70
DELISTED
Churchill Capital Corp V
CCV
$1.48M 0.15%
+148,845
New +$1.49M
QS icon
71
QuantumScape Corp
QS
$3.81B
$1.42M 0.15%
+250,000
New +$1.85M
KRE icon
72
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
$1.41M 0.15%
23,950
-99,750
-81% -$6.14M
NPWR icon
73
NET Power
NPWR
$139M
$1.39M 0.15%
+136,807
New +$1.37M
WFC icon
74
Wells Fargo
WFC
$265B
$1.39M 0.15%
33,640
-81,314
-71% -$3.6M
LHC
75
DELISTED
Leo Holdings Corp. II
LHC
$1.36M 0.14%
+135,000
New +$1.35M
1 2
3
4 5

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.